[1] |
LI Ai-fang, CUI Xiao-li, KANG Lei, LEI Jing, DANG Li-yun, YANG Han.
Value of fluorescence PCR probe melting curve method in detecting resistance of Mycobacterium tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(9): 998-1001.
|
[2] |
BAO Xun-di, JIANG Yue, LIANG Suo, CHENG Hong-yan, XIA Guang-xiu, WANG Chao, YE Qian, WANG Shu, WANG Qing.
Analysis of the clinical isolation rate, population distribution and drug resistance of non-tuberculous mycobacteria in Anhui
[J]. Chinese Journal of Antituberculosis, 2020, 42(7): 718-724.
|
[3] |
ZHANG Jing, CHEN Xi, WANG Bin, FU Lei, LU Yu, CHEN Xiao-you.
Establishment of modified propidium monoazide (PMAxx)-quantitative PCR assay and its application for identification of antituberculosis drug activity
[J]. Chinese Journal of Antituberculosis, 2020, 42(5): 472-480.
|
[4] |
YU Jia-jia, ZHANG Xu-xia, ZHANG Yu-qing, REN Wei-cong, YAO Cong, LI Chuan-you, LIU Yi, TANG Shen-jie.
Preliminary study on detection method of MTB DNA by PCR amplification combined with CRISPR-Cas13a system
[J]. Chinese Journal of Antituberculosis, 2020, 42(12): 1280-1288.
|
[5] |
LYU Chun-fang,WU Jian-hong,LU Liu-zhu,XU Yang-feng,LIU Sheng-yuan.
Comparative analysis of domestic real-time fluorescence quantitative PCR reagent and GeneXpert MTB/RIF for detecting Mycobacterium tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(1): 60-65.
|
[6] |
Dong-xin LIU,Hui-wen ZHENG,Wen-cong HE,Yi-meng SONG,Ping HE,Bing ZHAO,Xi-chao OU,Chun-fa LIU,Yan-Lin ZHAO.
Analysis of strains identification and drug susceptibility characteristics of non-tuberculous mycobacterium isolated in Guangzhou
[J]. Chinese Journal of Antituberculosis, 2019, 41(5): 534-540.
|
[7] |
Zhi-hua CAO,Yue-zhu ZHAO,Shuang-shuang HU.
Detection of drug resistance mutations in Mycobacterium tuberculosis to five antitubercular drugs using the fluorescent PCR probe melting curve method
[J]. Chinese Journal of Antituberculosis, 2019, 41(2): 156-161.
|
[8] |
SHI Lian,REN Yi-jie,XI Ying,SHI Lei,GUO Chen,GUAN Jian.
Detection value analysis of three laboratory techniques for diagnosing tuberculosis and drug resistance in smear-positive patients
[J]. Chinese Journal of Antituberculosis, 2019, 41(11): 1173-1178.
|
[9] |
Hui-na WU,Fu-sheng SUN,Qing-wen LIU,Zhong-lu RONG,Ji-dong ZHANG,Yang GAO,Yong-fu LI,Fei CHANG.
The value of fluorescent PCR probe melting curve analysis in detection of Mycobacterium tuberculosis complex for rifa-mpicin and isoniazid resistance
[J]. Chinese Journal of Antituberculosis, 2019, 41(1): 74-79.
|
[10] |
Li-ping CHENG,Xiao-yan ZHANG,Wei SHA.
The diagnostic value of sputum PCR-reverse dot blot hybridization in the diagnosis of suspected NTM pulmonary disease
[J]. Chinese Journal of Antituberculosis, 2018, 40(8): 834-839.
|
[11] |
Yu-jie DONG,Li ZHANG,Yu-xuan WANG,Li-juan ZHOU,Yang QU,Chen ZHANG,Hai-qing ZHANG,Nan-Ying CHE.
Clinical application of immunohistochemistry and PCR technique in pathological diagnosis of tuberculous lymphadenitis
[J]. Chinese Journal of Antituberculosis, 2018, 40(4): 348-352.
|
[12] |
SONG Yuan-yuan,LIU Er-yong,TAO Bo-shan,HUANG Fei-xiang,XIAO Ya-li,LAN Ru-shu,TAN Yun-hong,LI Hui,YE Lei,CHENG Shi-ming,ZHAO Yan-lin.
Evaluation the application of mycobacterial biphasic L-J medium in the diagnosis of tuberculosis
[J]. Chinese Journal of Antituberculosis, 2018, 40(12): 1325-1328.
|
[13] |
YANG Lei,WANG Guo-zhi,LU Jin-biao..
Discussion on the evaluation methods of tuberculosis pathogens diagnosis—Comment on “Expert consensus on molecular diagnostics of tuberculosis pathogens”
[J]. Chinese Journal of Antituberculosis, 2018, 40(12): 1355-1356.
|
[14] |
GUO Jun-hong,WU Chun-yan,DONG Zheng-wei,WU Wei,ZHANG Li-ping,LI Hui,HUANG Yan.
Clinical value of PCR test in diagnosis of pulmonary tuberculosis by using CT-guided lung biopsy specimens
[J]. Chinese Journal of Antituberculosis, 2018, 40(11): 1159-1163.
|
[15] |
LI Qiang, DONG Wei-jie, FAN Jun, QIN Shi-bing, GAO Meng-qiu.
Analysis of mycobacterial culture and drug sensitivity test in 38 patients with osteoarticular tuberculosis
[J]. Chinese Journal of Antituberculosis, 2017, 39(3): 277-281.
|